SUBSCRIBE: Print / eNewsletter
DCIS Recurrence Rates Cut in Half
Five-year recurrence rates for women with ductal carcinoma in situ have been cut in half recently due to advances in mammography and more detailed pathology assessments.
Adjuvant RT Extends Survival in Elderly TNBC Patients
Adjuvant radiation therapy after lumpectomy improves survival for elderly women with early-stage, triple-negative breast cancer, according to a study to be presented at the 2015 ASCO Breast Cancer Symposium.
WBRT Controls Brain Metastases But Does Not Impact Survival
Whole brain radiation therapy helps control tumor growth in patients with 1 to 3 small brain metastases, but it does not significantly extend patient survival.
Lenvatinib Plus Everolimus Improves Survival in Metastatic RCC
A combination of lenvatinib plus everolimus improved survival and overall response compared with everolimus alone in metastatic renal cell carcinoma patients.
Adding Olaratumab Dramatically Improves Survival in Soft-Tissue Sarcoma
Early trial results found that the addition of olaratumab to doxorubicin dramatically improves survival in patients with advanced soft-tissue sarcoma.
Heat Shock Protein Inhibitor May Benefit Bladder Cancer Patients
Advanced bladder cancer patients with poor prognosis appear to benefit from adding apatorsen 600 mg to first-line chemotherapy with gemcitabine/cisplatin.
Pembrolizumab Shows Antitumor Activity in Advanced Urothelial Cancer
Pembrolizumab demonstrates durable antitumor activity in patients with advanced urothelial cancer, with a higher response rate seen in patients with PD-L1 expression.
Adding Bevacizumab to Chemotherapy Improves PFS in Endometrial Cancer
The addition of bevacizumab to carboplatin/paclitaxel chemotherapy increases progression-free survival in advanced/recurrent endometrial cancer patients.
Eribulin Improves Survival in Advanced Sarcoma
Treating advanced sarcoma with the chemotherapy agent eribulin improves overall survival compared with treatment with standard therapy with dacarbazine.
Elective Dissection of Lymph Nodes Improves Survival in Early Oral Cancer
Elective neck lymph node surgery for patients with early oral cancer reduces the risk of cancer recurrence and improves survival.